Laima Trinkūnienė

home / authors / laimatrink-nien-

Laima Trinkūnienė, PhD candidate, is a scientist at Caszyme.

Articles

Genetic engineering, GMO and Gene manipulation, DNA gene editing, CRISPR-Cas9 gene editing tool | Image Source: © catalin -stock.adobe.com

CRISPR Gene-Editing Technology in the Development of Biopharmaceuticals

Laima Trinkūnienė;Giedrius Gasiūnas;Monika Paulė
June 9th 2025

Novel nucleases with diverse properties represent promising solutions, emphasizing their potential to overcome current limitations in genome editing and therapeutic delivery.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)
Published: October 11th 2024 | Updated: March 3rd 2025
Exploring New Advancements in ADC Technologies (CPHI Milan 2024)
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: July 20th 2020 | Updated: June 30th 2025
Contact BioPharm International Editors
BIO 2025: Building Relationships Amid a Rebrand
Published: June 19th 2025 | Updated: June 30th 2025
BIO 2025: Building Relationships Amid a Rebrand
PCI Pharma Services office in Mississauga, Ontario, Canada on September 19, 2020. PCI is an expert in pharmaceutical and biopharmaceutical supply chain solutions. | Image Credit: © JHVEPhoto - stock.adobe.com
Published: June 5th 2025 | Updated: June 30th 2025
PCI Pharma Services Introduces New Manufacturing Facility Ahead of BIO 2025
© 2025 MJH Life Sciences

All rights reserved.